Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Companies›Commodities›Chemicals›Chemicals & Petrochemicals

EMMESSAR BIOTECH & NUTRITION L

Chemicals › Chemicals & Petrochemicals
₹22.99
at close · 28 Oct 2026
▼ 0.01 (-0.04%)

Latest filings

Next results: Sat, 31 Oct · Financial Results
  1. Board meeting for September 2026 quarterly results · Results
  2. Q2 FY27 dematerialisation compliance certificate filed with BSE · Compliance
  3. Newspaper ad published for re-lodgement of physical share transfers · Compliance
All filings ↓
Ask Nexa about EMMESSAR BIOTECH & NUTRITION L

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates two reported segments on BSE — a small Healthcare (biotech/nutrition) business and rental income from a leasehold land holding — and is classified under Commodity Chemicals. In FY26, revenue from operations (the Healthcare segment) fell about 39% year-on-year to ₹37.08 lakh from ₹61.09 lakh, while total income of ₹240.66 lakh was supported by ₹165.31 lakh of rent on leasehold land booked as other income. Segment data for the year ending March 2026 shows Healthcare at ₹0.0928 crore, Rent on Leasehold Land at ₹0.4133 crore and Others at ₹0.0601 crore of period segment revenue. Profit after tax nevertheless rose 37.8% to ₹43.59 lakh (from ₹31.62 lakh) largely because the tax expense dropped from ₹64.20 lakh to ₹14.37 lakh. The company carries no debt and holds total assets of ₹9.5301 crore; employee cost of ₹1.0791 crore is several times its revenue from operations, indicating the core biotech activity is a very small contributor relative to fixed costs.

Operating scale
FY26 revenue from operations (Healthcare)
₹37.08 lakhFY26
FY26 rent on leasehold land
₹165.31 lakhFY26
Q3 FY26 revenue from operations
₹48.98 lakhQ3 FY26
9M FY26 revenue from operations
₹156.27 lakh9M FY26
Total assets
₹9.5301 croreFY26
Debt-to-equity
0FY26
Who pays it
Healthcare buyers for its biotech/nutrition products and a tenant on its leasehold land (specific counterparties not disclosed in the pack).
Biggest cost
Employee cost of ₹1.0791 crore, equal to 291% of FY26 revenue from operations.
Kind of business
Very small BSE-listed entity with a declining biotech core propped up by steady leasehold rent income; low operating scale, no debt.
Where it sits
Listed on BSE under the Chemicals & Petrochemicals / Commodity Chemicals classification, with revenue from operations of ₹37.08 lakh in FY26.
Market Cap
₹11 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
—·
ROCE
ROE — · margin —
Leverage
—·
Debt / Equity · borrowings not filed
Moves on a normal day
2.20%·
Median daily move
Last 265 sessions · the yardstick for filing-day moves
Where it sits among 66 Commodity Chemicals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#46/50
EBITDA margin#3/58

Scorecard

Measured from the filed financials, judged against its Commodity Chemicals peers — not investment advice

Not enough history to assess.

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from EMMESSAR BIOTECH & NUTRITION L's filed financials and exchange disclosures

What does EMMESSAR BIOTECH & NUTRITION L do?

EMMESSAR BIOTECH & NUTRITION L is a Chemicals & Petrochemicals company listed on BSE.

How much does the EMMESSAR BIOTECH & NUTRITION L share price move in a day?

On a typical session EMMESSAR BIOTECH & NUTRITION L moves 2.20% — that is the median absolute close-to-close move across its last 265 trading days. MarketPing measures each filing's price reaction against it.

When are EMMESSAR BIOTECH & NUTRITION L's next results?

Financial Results on Sat, 31 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track EMMESSAR BIOTECH & NUTRITION L's announcements?

Every NSE and BSE filing by EMMESSAR BIOTECH & NUTRITION L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.